specific Ts cells, culture and assay systems for plaque-forming cell (PFC) responses, mixed lymphocyte reactions (MLR), and cytotoxic lymphocyte (CTL) responses have been described in detail in the accompanying manuscript (5) .
Preparation ofHaplotype-specific TsF-H. Spleen cells from control mice or B10 or BALB/c mice injected as neonates with (B10.D2 × B10)FI spleen cells were incubated at 5 × 10 n cells/ well with 3 × 104 M~ of the appropriate allogeneic haplotype in completely supplemented Eagle's minimal essential medium with 10% fetal calf serum (lot 48006; Reheis Chemical Co., Kankakee, Ill.) in a final volume of 0.6 ml in 16-mm wells of a 24-multiwell tissue culture plate (76-033-05; Linbro Division, Flow Laboratories, Inc., Hamden, Conn.) for 48 h under modified Mishell-Dutton conditions (6, 7) . Culture supernates were collected, centrifuged at 1,500 rpm for 15 rain, filtered through 0.45-/z filters (Millipore Corporation, Bedford, Mass.), and stored at -70°C until use.
Generation of T Cell Hybridomas.
Spleen cells (5 × 10n/well) from BI0 mice injected with (B10.D2 × B10)F1 spleen cells as neonates were cultured with 3 × 104 B10.D2-M4~ for 24 h under modified Mishell-Dutton conditions (6, 7) . These activated cells were fused with the hypoxanthine-guanine phosphoribosyl transferase-deficient AKR thymoma, BW5147, using polyethylene glycol (8-I0) . Cells were cultured in hypoxanthine-aminopterin-thymidine selection medium (8, 10, 11) and scored for growth after 3-6 wk. Cells from primary wells that yielded supernatant fluids that caused >75% suppression of PFC responses by B 10 spleen cells were cloned by limiting dilution in soft agar over 3T3 feeder layers (8, 10, 12) . Individual colonies were plated and expanded, and supernatant fluids were retested for suppressive activity. The hybridoma to be discussed, clone 267.A4.A1, has been maintained in tissue culture for >6 mo without loss of activity and active cells have been recovered after freezing in liquid nitrogen. Supernatant fluids from BW5147 alone and from several wells of the same fusion were consistently negative for TsF-H activity or nonspecific suppressor activity. Culture supernates from 267.A4.AI collected from cells grown to confluence were processed in the same way as described for conventional TsF-H containing supernatant fluids. Some culture supernates or 267.A4.A1 supernates were concentrated 10 times by ultra filtration using a YM10 filter (Amicon Corporation, Lexington, Mass.) and applied to a Sephacryl S-200 column equilibrated with phosphate-buffered saline, pH 7.2. Fractions of 5.0 ml each were collected, filtered through 0.45-p filters, and assayed for suppressive activity in the PFC assay. ) anti-B10.D2 antisera was absorbed extensively on the H-2 mastocytoma P815 to remove all anti-K a activity. Rabbit anti-mouse IgG was prepared as described by Theze et al. (13) . The immunoglobulin fractions of the heat-inactivated antisera were used to prepare Sepharose immunoabsorbents.
Results
Demonstration ofHaplotype-specific TsF-H. Spleen cells from neonatally treated B10 mice, containing haplotype-specific Ts cells, were cultured with Mq) of the appropriate and inappropriate haplotype for 48 h; the culture supernates were tested for the ability to suppress primary in vitro PFC responses by syngeneic spleen cells to Lglutamic acid6°-L-alaninea°-L-tyrosine 1° (GAT) and sheep erythrocytes (SRBC). Supernatant fluids from spleen cells restimulated with Mq~ of the allogeneic haplotype encountered neonatally (B10.D2) profoundly suppressed primary responses to GAT and SRBC (Fig. 1 ). Suppression was observed over a substantial range of dilutions; the final dilution of TsF-H producing 50% suppression varied with individual preparations of TsF-H, but was in the range of 1:500 to 1:1,000. TsF-H activity was not observed in culture fluids prepared from normal B 10 cells in an identical manner (data not shown) or in supernates of neonatally treated B10 spleen cells stimulated with C3H M~b. TsF-H derived from treated B 10 spleen cells had no effect on responses by BALB/c spleen cells to SRBC (data not shown). No difference in cell number or in viability was observed in cultures with control or active TsF-H. The cell responsible for production of TsF-H was determined by stimulating different spleen cell populations with the appropriate M~ and testing culture supernates for suppressive activity; only T cells from lymph node or spleen, but not thymus, produced TsF-H (data not shown). These findings were consistent with those for Ts cells (5) , and prompted attempts to produce T cell hybridomas producing TsF-H by fusion of Ts cells with the thymoma line BW5147. Supernatant fluids from the 27 wells positive for growth out of a total of 60 wells plated were tested for suppression of primary in vitro PFC responses. The eight wells showing suppressive activity were cloned in soft agar, individual colonies were picked and grown in suspension culture, and supernates were retested for their ability to suppress primary PFC responses. Activity was demonstrated in two wells of the 24 that gave growth, with significant suppression in clone 267.A4.A1 seen at a dilution of 1:600,000 (Fig. 1) . Culture supernates from the thymoma fusion partner, BW5147, failed to show suppression over the dilution ranges tested.
Parameters of TsF-H Activity. The ability of conventional and hybridoma TsF-H to suppress primary and secondary in vitro PFC responses MLR and CTL responses were examined. Significant suppression of primary in vitro PFC responses to GAT and SRBC was demonstrated over a wide range of dilutions of TsF-H (Table I); primary TNP-specific PFC responses to TNP-SRBC and TNP-Brucella abortus were also suppressed (data not shown). Similar amounts of TsF-H failed to suppress secondary in vitro PFC responses (Table I) or MLR or CTL responses (Table II) ; this lack of antigen specificity and failure to suppress secondary PFC responses and MLR and CTL responses were observed with the Ts cells (5) . Analysis of the kinetics of suppression showed that conventional or hybridoma TsF-H must be present during the first 36-48 h of culture to achieve significant suppression and that TsF-H added at culture initiation blocked development of a significant PFC response (Fig. 2) . (Table III) . Using spleen cells from B10 mice neonatally treated with (B10.D2 × B10)F1 cells, B10.D2 and B10.GD M~ stimulate TsF-H production, whereas B10.
LG M4~ failed to stimulate TsF-H production, demonstrating that syngenicity at the I-A subregion of the H-2 complex between the stimulator Mff and the allogeneic haplotype used to treat neonates was necessary and sufficient. Genetic restrictions on the activity of TsF-H were investigated using responder spleen cells from mice sharing various regions of the H-2 complex with the TsF-Hproducing cells. Significant suppression was observed only when the TsF-H-producing cell and the responder target spleen cells shared an identity at the I-A subregion of the H-2 complex (Table IV) . This was demonstrated by the ability of B10 TsF-H to suppress primary responses by B10, B10.A(3R), and B10.A(5R) spleen cells, but not B 10.A(4R) spleen cells (this does not exclude the requirement for identity at K) and BALB/c TsF-H to suppress PFC responses by B10.GD but not B10.LG spleen cells. An interesting point was the lack of a requirement for syngenicity at the I-J subregion between the TsF-H-producing cell and its target population identity, which is required in some other suppressor systems (3, 4) .
Characterization of Conventional and Hybridoma TsF-H
MOLECULAR WEIGHT DETERMINATION, The relative molecular weight of TsF-H was determined by gel filtration through a Sephacryl S-200 column. TsF-H activity was recovered in fractions collected between the bovine serum albumin (BSA) and ovalbumin (OVA) markers, placing the apparent molecular weight in the range of 45,000 to 68,000 (Fig. 3) .
SENSITIVITY TO HEAT, pa, AND TRYPSIN. The stability of TsF-H under different temperatures, pH, and treatment with trypsin was examined (Table V) . Biological activity was destroyed at 60°C (partially at 40°C) for 30 min, by pH 3.5, and by treatment with trypsin, which suggests that TsF-H is a protein and that some degree of tertiary structure was required for activity. (Table  VI) suppressor factor of the appropriate specificity (J. Kapp, personal communication). Rabbit anti-mouse Ig or rabbit anti-mouse Fab reagents failed to absorb either B10 or BALB/c TsF-H. These results strongly suggest that TsF-H does not bear classical immunoglobulin constant-region determinants, but does bear determinants encoded by the I-A subregion of the H-2 complex.
TABL~ V

Partial Characterization of TsF-H
absorbed by a (B10.A X A) anti-B10.A (5R), anti-(KAB) b immunoabsorbent
Discussion
Suppressive activity has been demonstrated in supernatant fluids of spleen Cells from mice treated as neonates with semiallogeneic F1 spleen cells cultured with M~ of the allogeneic H-2 haplotype encountered as neonates. Production of TsF-H required T cells (lymph node or spleen, but not thymus) from mice treated as neonates and M(h syngeneic at the I-A subregion of H-2 with the allogeneic partner used in the neonatal treatment. TsF-H suppressed only primary in vitro antibody responses by spleen cells from mice sharing identity at the I-A subregion with the mice producing TsF-H. In vivo activity of TsF-H is currently being tested. TsF-H, although restricted genetically with respect to production and interaction with target cells, was nonantigen-specific and suppressed responses to both T cell-dependent and T cellindependent antigens. TsF-H failed to suppress secondary antibody responses and MLR or CTL responses. TsF-H is a protein with a molecular weight in the range of 45,000-68,000 that bears determinants of the I-A subregion of the H-2 complex but not demonstrable Ig constant-region determinants. A T cell hybridoma producing monoclonal TsF-H with identical activities and properties has been produced by fusion of the AKR thymoma BW5147 with T cells from B10 mice treated as neonates with (B10.D2 × B10)F1 cells (8) .
Numerous examples of Ts cells and soluble suppressor molecules that mediate their effects have been reported (3, 4, (14) (15) (16) (17) (18) ; these diverse systems have been compared, contrasted, and integrated by Germain and Benacerraf (14) . The suppressor pathway is initiated by the interaction of antigen with antigen-specific Ly-1 + or Ly-l,2,3 + (frequently I-J +) Ts cells that produce suppressor factors (TsF1) that act across H-2 and VH differences. These factors are proteins with molecular weights of ~50,000 that bind antigen, bear I-J determinants, and, where tested, bear the appropriate idiotype of the system. These TsF1 appear to induce together with antigen a second set of Ts cells (Ts~ cells) that are Ly-l,2,3 +, I-J +, and either antigen-specific or specific for idiotype (i.e., anti-idiotypic). These cells or a succeeding set of Ly-2,3 +, I-J + effector Ts cells produce suppressor factors (TsF2) whose activity is restricted by H-2 (I-J subregion) and, for anti-idiotypic Ts2, VH-linked genes. These TsF2 are also proteins with a molecular weight of ~50,000 that are I-J + and bear receptors for antigen or idiotype in cases where activity is restricted by VH-linked genes. Finally, antigenprimed Ly-1,2,3 +, I-J +, idiotype-positive Ts3 cells after appropriate activation produce nonspecific suppressor factors that appear ultimatelyto mediate suppression. Important distinctions exist between these various antigen-specific suppressor factors and the haplotype-specific suppressor factor described here apart from the lack of antigen specificity. The antigen-specific suppressor factors described to date bear determinants encoded by the I-J (in one case I-C) subregion of the H-2 gene complex (3, 4, 14) . Tada (3, 19) reports a strict requirement for syngenicity at I-J between a TsF2 and its target cell, whereas Kapp (20) demonstrated the presence of I region determinants (presumably I-J determinants) on the GAT-TsF, most likely a TsF1, but showed that GAT-TsF from nonresponders can cross-suppress responses by other nonresponder cells (3, 14) . Other suppressor factors in the GT system (4, 14) , the feedback suppressor pathway in responses to SRBC (14, 15) , and delayed hypersensitivity to the azobenzenearsonate and 4-hydroxy-3-nitrophenyl acetate systems (4, 14, 17) , are presumably in the TsF1 class, and are I-J + and not H-2-restricted. A suppressor factor involved in contact hypersensitivity responses bears I-C subregion products and is H-2-restricted and is therefore in the TsF2 class (14, 16) . In contrast, we have been unable to demonstrate I-J determinants on TsF-H or a restriction in TsF-H activity by the I-J subregion. Instead, TsF-H activity is restricted by the I-A subregion and I-A determinants are present on TsF-H. This same lack of involvement of I-J, and restriction by products of the I-A subregion was observed with the haplotype-specific Ts cell itself (5). These findings and others bring into question the actual role, if any, of I-J determinants in suppression. One possibility is that the I-J subregion encodes more than one product, and that distinct I-J products are expressed by the various precursor, inducer, and effector cells in the helper-suppressor T cell circuits (3, 14, 21, 22 ; D. Murphy, personal communication). The existence of distinct I-J products on these ceils could be the basis for their interrelationship and communication. The presence of I-J determinants on the haplotype-specific Ts cell has not been ruled out; studies to date have only shown that the I-J subregion does not restrict either the suppressor ceils or TsF-H. Studies are in progress to determine the surface phenotype of these suppressor cells and to examine the possibility that I-J determinants other than those classically expressed on Ts cells (3, 4, 14, 19, 22 ; D. Murphy, personal communication) are expressed on the cells or the factor.
The haplotype-specific Ts cell-TsF-H system has more similarities to the MLR suppressor system of Rich and Rich (23) (24) (25) than to the antigen-specific systems. This system is activated after exposure to alloantigens in vivo and restimulation in vitro; activated Ts cells are short-lived cells that act via a factor MLR-TsF that suppresses the MLR in a genetically restricted but non-antigen-specific manner (24, 25) . Syngenicity at I-J between factor and target cell for expression of MLR-TsF activity is not required; instead, syngenicity at the I-E/C subregion of H-2 is necessary and sufficient. It is interesting to speculate about why suppressor systems in response to Isubregion-encoded determinants appear to have regulatory or genetic constraints that differ from Ts ceils that are stimulated by conventional antigens. Suppressor systems involving conventional antigens are intimately associated with I-J subregion regulation, whereas the haplotype-specific and MLR Ts systems do not appear to involve the I-J subregion, but are regulated by I-A and/or I-E/C subregions. The major exception, the contact hypersensitivity suppressor system (16) is regulated by the I-C subregion. However, this system and the suppressor systems involving delayed hypersensitivity to azobenzenearsonate and 4-hydroxy-3-nitrophenyl acetate are activated by presenting the relevant determinant to the immune system on lymphoid cells whose I-region products may be modified by these determinants (14) . Thus, these hypersensitivity suppressor systems and the MLR and haplotype-specific suppressor systems are examples of Ts systems that, because of the critical involvement of Iregion products in their activation, may not be regulated by the I-J subregion. Regulation of suppressor systems involving conventional antigens, which may or may not be presented in the context of I-region products, but which do not involve responses to I-region products or modified I-region products, may be regulated exclusively by I-J subregion products. Further data that should be forthcoming from several laboratories should answer these questions.
Further, studies on the biochemical nature, structure, and mechanism of the action of TsF-H will be facilitated by the availability of T cell hybridomas producing monoclonal TsF-H. Preliminary studies indicate that TsF-H induces another population of T cells to produce a second factor that acts in a non-antigen-specific, non-MHC-restricted fashion to inhibit antibody responses. Characterization of these cells and their factor is in progress.
Summary
Culture supernatant fluids from spleen cells from C57BL/10 or BALB/c mice neonatally treated with semiallogeneic (B10.D2 × B10)FI cells to induce haplotypespecific suppressor T cells and restimulated with macrophages syngeneic at I-A with the allogeneic haplotype encountered as neonates contain a soluble factor capable of suppressing primary in vitro antibody responses of normal syngeneic spleen cells in a non-antigen-specific manner. This haplotype-specific suppressor factor, TsF-H, has also been recovered in culture fluids of a T cell hybridoma produced by fusion of the AKR thymoma BW5147 and the haplotype-specific suppressor T cells. TsF-H is inactivated by low pH (3.5) trypsin, for 30 min at 50°C, and has a molecular weight in the range of 45,000 to 68,000. Studies with specific immunoabsorbents demonstrate the presence of determinants encoded by the I-A subregion of the haplotype of the T cell producing TsF-H but not I-J subregion or immunoglobulin constant-region determinants on the TsF-H. Suppression is restricted to primary in vitro antibody responses, and not secondary antibody, mixed lymphocyte, or cytotoxic lymphocyte responses by spleen cells syngeneic at the I-A subregion of H-2 with the T cell producing the factor. The properties and activities of TsF-H and the haplotypespecific suppressor T cell are compared and contrasted with antigen-specific and genetically restricted suppressor T cells and their factors.
